Lung cancer: biology and technology foster therapeutic innovation.
作者信息
Mountzios Giannis
机构信息
Department of Medical Oncology and Translational Research Athens, University of Athens School of Medicine, Athens, Greece.
Second Department of Medical Oncology, Henry Dunant Hospital Center, Athens, Greece.
出版信息
Ann Transl Med. 2018 Apr;6(8):137. doi: 10.21037/atm.2018.04.19.
Abstract
摘要
相似文献
1
Lung cancer: biology and technology foster therapeutic innovation.肺癌：生物学与技术推动治疗创新。
Ann Transl Med. 2018 Apr;6(8):137. doi: 10.21037/atm.2018.04.19.
2
[Medical technology innovation: why get involved and how?].
Rev Med Suisse. 2013 Jun 19;9(391):1323-6.
3
Let's (not) talk about synthetic biology: Framing an emerging technology in public and stakeholder dialogues.让我们（不要）谈论合成生物学：在公众和利益相关者对话中构建新兴技术的框架。
Public Underst Sci. 2020 Jul;29(5):492-507. doi: 10.1177/0963662520907255. Epub 2020 Mar 3.
4
Cooperation and Competition in the Innovation Ecosystem From the Perspective of Evolutionary Psychology.从进化心理学视角看创新生态系统中的合作与竞争
Front Psychol. 2021 Nov 18;12:769847. doi: 10.3389/fpsyg.2021.769847. eCollection 2021.
5
Research on the coupling mechanism and influencing factors of digital economy and green technology innovation in Chinese urban agglomerations.中国城市群数字经济与绿色技术创新的耦合机制及影响因素研究
Sci Rep. 2024 Mar 2;14(1):5150. doi: 10.1038/s41598-024-55854-4.
6
From individual innovation to global impact: the Global Cooperation on Assistive Technology (GATE) innovation snapshot as a method for sharing and scaling.从个体创新到全球影响：辅助技术全球合作（GATE）创新概况作为一种分享与推广的方法
Disabil Rehabil Assist Technol. 2018 Jul;13(5):486-491. doi: 10.1080/17483107.2018.1467971. Epub 2018 May 9.
7
Fostering Responsible Innovation in Health: An Evidence-Informed Assessment Tool for Innovation Stakeholders.促进健康领域的负责任创新：创新利益相关者的循证评估工具。
Int J Health Policy Manag. 2021 Mar 14;10(4):181-191. doi: 10.34172/ijhpm.2020.34.
8
Do-it-yourself biology: challenges and promises for an open science and technology movement.自制生物学：开放科学与技术运动面临的挑战与机遇
Syst Synth Biol. 2013 Sep;7(3):115-26. doi: 10.1007/s11693-013-9116-4. Epub 2013 Aug 2.
9
[Integration of innovation & entrepreneurship concept with the teaching practice of biochemistry experiment].创新创业理念与生物化学实验教学实践的融合
Sheng Wu Gong Cheng Xue Bao. 2021 Jul 25;37(7):2581-2588. doi: 10.13345/j.cjb.200751.
10
How can entrepreneurs experience inform responsible health innovation policies? A longitudinal case study in Canada and Brazil.企业家如何体验信息负责任的健康创新政策？加拿大和巴西的纵向案例研究。
Int J Health Plann Manage. 2023 Jul;38(4):967-985. doi: 10.1002/hpm.3636. Epub 2023 Mar 29.
本文引用的文献
1
Advances on systemic treatment for lung neuroendocrine neoplasms.肺神经内分泌肿瘤全身治疗的进展
Ann Transl Med. 2018 Apr;6(8):146. doi: 10.21037/atm.2018.04.03.
2
Advanced small cell lung cancer (SCLC): new challenges and new expectations.晚期小细胞肺癌：新挑战与新期望。
Ann Transl Med. 2018 Apr;6(8):145. doi: 10.21037/atm.2018.03.31.
3
Implementation of immunotherapy in the treatment of advanced non-small cell lung cancer (NSCLC).免疫疗法在晚期非小细胞肺癌（NSCLC）治疗中的应用。
Ann Transl Med. 2018 Apr;6(8):144. doi: 10.21037/atm.2018.02.07.
4
Breakthroughs in the treatment of advanced squamous-cell NSCLC: not the neglected sibling anymore?晚期鳞状非小细胞肺癌治疗的突破：不再是被忽视的“兄弟”了？
Ann Transl Med. 2018 Apr;6(8):143. doi: 10.21037/atm.2018.02.18.
5
Beyond and : targeting rare mutations in advanced non-small cell lung cancer.超越 和 ：靶向晚期非小细胞肺癌中的罕见突变。
Ann Transl Med. 2018 Apr;6(8):142. doi: 10.21037/atm.2018.04.28.
6
Treating ALK-positive non-small cell lung cancer.治疗间变性淋巴瘤激酶（ALK）阳性非小细胞肺癌。
Ann Transl Med. 2018 Apr;6(8):141. doi: 10.21037/atm.2017.11.34.
7
Making progress in epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer by surpassing resistance: third-generation EGFR tyrosine kinase inhibitors (EGFR-TKIs).克服耐药性，在表皮生长因子受体（EGFR）突变的非小细胞肺癌治疗中取得进展：第三代EGFR酪氨酸激酶抑制剂（EGFR-TKIs）
Ann Transl Med. 2018 Apr;6(8):140. doi: 10.21037/atm.2017.10.04.
8
Novel chemotherapy regimens for advanced lung cancer: have we reached a plateau?晚期肺癌的新型化疗方案：我们是否已达到瓶颈？
Ann Transl Med. 2018 Apr;6(8):139. doi: 10.21037/atm.2018.04.04.
9
The emerging treatment landscape of advanced non-small cell lung cancer.晚期非小细胞肺癌的新兴治疗格局
Ann Transl Med. 2018 Apr;6(8):138. doi: 10.21037/atm.2017.11.07.
Zotero 插件